Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1379325-64-0

Post Buying Request

1379325-64-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1379325-64-0 Usage

Uses

3''-Bromo-5''-methylacetophenone is synthesized from 3-bromo-5-methylbenzoic acid which is used in the evaluation of quinoline amide derivatives as novel VEGFR-2 inhibitors.

Check Digit Verification of cas no

The CAS Registry Mumber 1379325-64-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,7,9,3,2 and 5 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1379325-64:
(9*1)+(8*3)+(7*7)+(6*9)+(5*3)+(4*2)+(3*5)+(2*6)+(1*4)=190
190 % 10 = 0
So 1379325-64-0 is a valid CAS Registry Number.

1379325-64-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(3-bromo-5-methylphenyl)ethanone

1.2 Other means of identification

Product number -
Other names 1-(3-bromo-5-methylphenyl)ethan-1-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1379325-64-0 SDS

1379325-64-0Upstream product

1379325-64-0Downstream Products

1379325-64-0Relevant articles and documents

CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE

-

Paragraph 000640; 000642; 000645; 000646, (2018/01/17)

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme ceramide galactosyltransferase (CGT), such as, for example, lysosomal storage diseases. Examples of lysosomal storage diseases include, for example, Krabbe disease and Metachromatic Leukodystrophy.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1379325-64-0